| 000 | 01152 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515051409.0 | ||
| 264 | 0 | _c20070205 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a1173-2563 | ||
| 024 | 7 |
_a10.2165/00044011-200626080-00006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlagozlu, Hakan | |
| 245 | 0 | 0 |
_aSevere INR elevation in a patient with choledocholithiasis receiving cefoperazone. _h[electronic resource] |
| 260 |
_bClinical drug investigation _c2006 |
||
| 300 |
_a481-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 |
_aCefoperazone _xadverse effects |
| 650 | 0 | 4 |
_aCholedocholithiasis _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoprothrombinemias _xblood |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 | _aProthrombin Time |
| 700 | 1 | _aCindoruk, Mehmet | |
| 700 | 1 | _aUnal, Selahattin | |
| 773 | 0 |
_tClinical drug investigation _gvol. 26 _gno. 8 _gp. 481-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00044011-200626080-00006 _zAvailable from publisher's website |
| 999 |
_c16731854 _d16731854 |
||